Krebs Biochemicals and Industries Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

Krebs Biochemicals & Industries Ltd's board has approved the financial results for the quarter ended June 30, 2025. The company announced significant leadership changes: Mr. Manish Kumar Jain has been appointed as an Additional Director and Managing Director & CEO, pending shareholder approval. This follows the resignation of Mr. Jitendra Shah as MD/CEO and Director. The board has also reconfigured its Audit Committee and Stakeholder Relationship Committee to reflect these updates. #KREBSBIO #BoardMeeting #CorporateUpdate